Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al
Andrology
.
2013 Nov;1(6):802-5.
doi: 10.1111/j.2047-2927.2013.00151.x.
Authors
A C Gore
1
,
J Balthazart
,
D Bikle
,
D O Carpenter
,
D Crews
,
P Czernichow
,
E Diamanti-Kandarakis
,
R M Dores
,
D Grattan
,
P R Hof
,
A N Hollenberg
,
C Lange
,
A V Lee
,
J E Levine
,
R P Millar
,
R J Nelson
,
M Porta
,
M Poth
,
D M Power
,
G S Prins
,
E C Ridgway
,
E F Rissman
,
J A Romijn
,
P E Sawchenko
,
P D Sly
,
O Söder
,
H S Taylor
,
M Tena-Sempere
,
H Vaudry
,
K Wallen
,
Z Wang
,
L Wartofsky
,
C S Watson
Affiliation
1
Division of Pharmacology and Toxicology, The University of Texas, Austin, TX, USA.
PMID:
24166945
DOI:
10.1111/j.2047-2927.2013.00151.x
No abstract available
Publication types
Letter
Comment
MeSH terms
Advisory Committees*
Animals
Endocrine Disruptors / standards*
Endocrine Disruptors / toxicity*
Humans
Substances
Endocrine Disruptors
Grants and funding
R01 AR038386/AR/NIAMS NIH HHS/United States
R01 AR050023/AR/NIAMS NIH HHS/United States